(Q34906456)

5 August 2017

1 reference

title

Oral combination therapy for type 2 diabetes (English)

1 reference

5 August 2017

0 references

Guillaume Charpentier

series ordinal

1

1 reference

5 August 2017

1 September 2002

1 reference

Diabetes - Metabolism: Research and Reviews

5 August 2017

1 reference

5 August 2017

18 Suppl 3

1 reference

5 August 2017

S70-6

1 reference

Oral antihyperglycaemics. Considerations in older patients with non-insulin-dependent diabetes mellitus

5 August 2017

1 reference

Therapeutic objectives and their practical achievement in type 2 diabetes

21 January 2018

1 reference

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

Combining sulfonylureas and other oral agents

21 January 2018

1 reference

Improving glycaemic control with current therapies.

21 January 2018

1 reference

Pharmacologic therapy for type 2 diabetes mellitus

21 January 2018

1 reference

21 January 2018

1 reference

21 January 2018

1 reference

Rosiglitazone short-term monotherapy lowers fasting and post-prandial glucose in patients with type II diabetes.

21 January 2018

1 reference

Rosiglitazone taken once daily provides effective glycaemic control in patients with Type 2 diabetes mellitus.

21 January 2018

1 reference

Pioglitazone hydrochloride monotherapy improves glycemic control in the treatment of patients with type 2 diabetes: a 6-month randomized placebo-controlled dose-response study. The Pioglitazone 001 Study Group.

21 January 2018

1 reference

Oral antidiabetic agents. A guide to selection

21 January 2018

1 reference

PPAR gamma and the treatment of insulin resistance

21 January 2018

1 reference

Rationale for the association of sulfonylurea and insulin

21 January 2018

1 reference

Troglitazone: antihyperglycemic activity and potential role in the treatment of type 2 diabetes

21 January 2018

1 reference

Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study Group.

21 January 2018

1 reference

Antihyperglycaemic efficacy, response prediction and dose-response relations of treatment with metformin and sulphonylurea, alone and in primary combination.

21 January 2018

1 reference

Troglitazone in combination with sulfonylurea restores glycemic control in patients with type 2 diabetes. The Troglitazone Study Group.

21 January 2018

1 reference

A comparison of acarbose versus metformin as an adjuvant therapy in sulfonylurea-treated NIDDM patients.

21 January 2018

1 reference

The efficacy of acarbose in the treatment of patients with non-insulin-dependent diabetes mellitus. A multicenter controlled clinical trial.

21 January 2018

1 reference

Effects of oral hypoglycemic agents and diet on protein metabolism in type 2 diabetes.

21 January 2018

1 reference

Efficacy and metabolic effects of metformin and troglitazone in type II diabetes mellitus.

21 January 2018

1 reference

Effect of metformin and rosiglitazone combination therapy in patients with type 2 diabetes mellitus: a randomized controlled trial.

21 January 2018

1 reference

Efficacy and safety of acarbose in metformin-treated patients with type 2 diabetes.

21 January 2018

1 reference

Triple oral antidiabetic therapy

21 January 2018

1 reference

Risk factors for antihypertensive medication refill failure by patients under Medicaid managed care.

21 January 2018

1 reference

Antihyperglycaemic agents. Drug interactions of clinical importance

21 January 2018

1 reference

Management of non-insulin-dependent diabetes mellitus in Europe: a concensus view

21 January 2018

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Comparison of acarbose and metformin in patients with Type 2 diabetes mellitus insufficiently controlled with diet and sulphonylureas: a randomized, placebo-controlled study

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

UKPDS 28: a randomized trial of efficacy of early addition of metformin in sulfonylurea-treated type 2 diabetes. U.K. Prospective Diabetes Study Group

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/DMRR.278

1 reference

5 August 2017

1 reference

PubMed ID

12324989